Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
20.24
0.47 (2.38%)
At close: Aug 15, 2025, 3:59 PM
20.22
-0.10%
After-hours: Aug 15, 2025, 06:46 PM EDT
Enliven Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 119.44M | 101.7M | 124.12M | 100.62M | 96.87M | 149.22M | 100.19M | 73.85M | 125.72M | 292.1M | 88.2M | 86.16M | 30.43M | 36.48M | 110.02M | 75.3M | 48.04M | 53.44M |
Short-Term Investments | 371.07M | 187.85M | 189.32M | 191.21M | 215.52M | 171.34M | 153.01M | 189.63M | 152.15M | n/a | n/a | 6.81M | 29.91M | 36.42M | 41.97M | 27.54M | 18.73M | 22.15M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 54K | 54K | 54K | n/a | n/a | 175K | 175K | 41.97M | 175K | 175K | 88K |
Other Long-Term Assets | 7.24M | 7.2M | 7.17M | 7.8M | 8.13M | 4.65M | 4.65M | 4.18M | 3.93M | 3.4M | 807K | 1.01M | n/a | n/a | -40.26M | n/a | n/a | 220K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 5.12M | 4.76M | 4.69M | 5.16M | 5.74M | 10M | 12.95M | 5.13M | 5.31M | 5.9M | 1.44M | n/a | 3.92M | 5.63M | n/a | 3.16M | 4.59M | 4.77M |
Total Current Assets | 495.62M | 294.32M | 318.13M | 297M | 318.13M | 337.2M | 266.15M | 268.61M | 283.18M | 298M | 89.64M | 88.23M | 64.26M | 78.53M | 110.67M | 106M | 71.36M | 80.36M |
Property-Plant & Equipment | 1.03M | 1.05M | 458K | 630K | 791K | 924K | 1.06M | 1.2M | 1.34M | 1.4M | 1.52M | 1.55M | 235K | 2.9M | 954K | 855K | 936K | 1.02M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 8.27M | 8.25M | 7.63M | 8.43M | 8.92M | 5.58M | 5.72M | 5.43M | 5.33M | 4.86M | 2.32M | 2.57M | 410K | 3.07M | 2.66M | 1.03M | 1.11M | 1.33M |
Total Assets | 503.89M | 302.57M | 325.76M | 305.43M | 327.04M | 342.78M | 271.87M | 274.04M | 288.5M | 302.87M | 91.96M | 90.8M | 64.67M | 81.6M | 113.33M | 107.03M | 72.47M | 81.69M |
Account Payables | 2.35M | 1.56M | 1.34M | 1.02M | 1.08M | 2.73M | 532K | 1.49M | 2.84M | 5.86M | 3.44M | 2.99M | 1.14M | 1.88M | 2.52M | 2.48M | 2.63M | 3M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.63M | n/a | -323K | n/a | n/a | n/a | 2.7M | n/a | n/a | n/a |
Short-Term Debt | n/a | 365K | n/a | 85K | 169K | 252K | 335K | 332K | n/a | n/a | n/a | n/a | 445K | 508K | n/a | 250K | 254K | 257K |
Other Current Liabilities | 15.21M | 1.79M | 4.81M | 3.61M | 9.09M | 19.99M | 21.36M | 36K | 4.2M | 3.72M | 1.64M | 1.08M | 1.05M | 3.7M | 233K | 2.9M | 3M | 1.58M |
Total Current Liabilities | 15.21M | 13.97M | 15.91M | 17.03M | 22.11M | 25.03M | 25.89M | 12.08M | 9.15M | 10.94M | 1.83M | 8.33M | 3.3M | 7.22M | 5.75M | 7.19M | 6.97M | 5.5M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 466K | 528K | 590K |
Other Long-Term Liabilities | 204K | 302K | n/a | n/a | 6K | 34K | 67K | 214K | 360K | 508K | 150.41M | 150.56M | 1.58M | n/a | 150.46M | -466K | -528K | -590K |
Total Long-Term Liabilities | 204K | 302K | n/a | n/a | 6K | 34K | 67K | 214K | 360K | 508K | 150.41M | 150.56M | 1.58M | 1.97M | 150.46M | 466K | 528K | 590K |
Total Liabilities | 15.41M | 14.27M | 15.91M | 17.03M | 22.11M | 25.07M | 25.96M | 12.29M | 9.51M | 11.45M | 1.83M | 158.89M | 3.3M | 9.19M | 156.22M | 7.65M | 7.5M | 6.09M |
Total Debt | n/a | 365K | n/a | 85K | 169K | 252K | 335K | 332K | 329K | 326K | 323K | 320K | 445K | 2.48M | 159K | 716K | 782K | 847K |
Common Stock | 59K | 49K | 49K | 47K | 47K | 47K | 41K | 41K | 41K | 41K | 27K | 1K | 27K | 27K | 1K | 27K | 19K | 18K |
Retained Earnings | -297.35M | -272.02M | -243.47M | -220.29M | -197.14M | -177.19M | -154.45M | -135.08M | -114.31M | -97.59M | -146.01M | -73.31M | -173.59M | -162.14M | -45.2M | -133.18M | -119.53M | -106.37M |
Comprehensive Income | -177K | -16K | 55K | 242K | -139K | -53K | 141K | -147K | -111K | -0.00 | -176.75K | -4K | -35K | -51K | -16K | -2K | n/a | 1K |
Shareholders Equity | 488.47M | 288.3M | 309.85M | 288.4M | 304.93M | 317.71M | 245.91M | 261.75M | 278.99M | 291.42M | 90.13M | -68.1M | 61.36M | 72.41M | -42.89M | 99.37M | 64.97M | 75.59M |
Total Investments | n/a | 187.85M | 189.32M | 191.21M | 215.52M | 171.34M | 153.01M | 189.63M | 152.15M | 54K | n/a | 6.81M | 30.08M | 36.59M | 41.97M | 27.72M | 18.91M | 22.24M |